Kevin Lim

Optellum was founded so that every lung cancer patient is treated at the earliest possible stage, and cured. We are redefining early interception of lung disease, by enabling every clinician, in every hospital, to manage their patients in the optimal way. Our first product is the first Clinical Decision Support software for personalized early diagnosis & treatment of lung cancer, based on Artificial Intelligence & Machine Learning applied to the world’s largest clinical dataset. We are a team of world-leading medical imaging software, AI, and clinical experts who met at Oxford’s world-renowned computer vision laboratory. Between us, we have track records of bringing innovation to market through over 10 start-up companies, resulting already in 5 trade-sales and one IPO. We are backed by an Advisory Board comprising world-leading clinicians (global authors of medical guidelines) and experts in deep learning. We are building up our development team – join our fight against cancer, working together with former software engineers from top technology companies (Amazon, Facebook, Redhat) and veterans of medical imaging startups. Learn more at http://www.optellum.com/.

BluMaiden Biosciences is a biotechnology company that adopts a human-first approach. We enable better drug discovery by probing the vastness of chemical space hidden within the human microbiome. Leveraging immense AI-powered computational genetics and chemistry engines, we illuminate new frontiers for new medicines. The Company is currently involved in several clinical trials and collaborations with clinical institutions, biotechnology companies, and Pharma to address challenges and provide enhanced support in clinical research and drug discovery. Run by an accomplished founding team and backed by a panel of experienced global investors and scientific advisors, BluMaiden is building a sustainable business with an enduring competitive advantage.

Edtopia was founded in 2018 as an Oxford University edtech spinout with a mission to make outstanding education available to all. The company's adaptive learning IP - developed by Professor Francis Brown - supported over a million users to benefit from personalised learning and was the subject of a private acquisition in 2021.

Perspectums imaging solutions are safe, fast, and can offer more comprehensive diagnostics. We help doctors understand complex data and help deliver precision care to more patients. We believe the voice of the patient matters and that each case is unique. Our goal is to enable health care providers to tailor precision medicine to the needs of the individual.

Optellum was founded so that every lung cancer patient is treated at the earliest possible stage, and cured. We are redefining early interception of lung disease, by enabling every clinician, in every hospital, to manage their patients in the optimal way. Our first product is the first Clinical Decision Support software for personalized early diagnosis & treatment of lung cancer, based on Artificial Intelligence & Machine Learning applied to the world’s largest clinical dataset. We are a team of world-leading medical imaging software, AI, and clinical experts who met at Oxford’s world-renowned computer vision laboratory. Between us, we have track records of bringing innovation to market through over 10 start-up companies, resulting already in 5 trade-sales and one IPO. We are backed by an Advisory Board comprising world-leading clinicians (global authors of medical guidelines) and experts in deep learning. We are building up our development team – join our fight against cancer, working together with former software engineers from top technology companies (Amazon, Facebook, Redhat) and veterans of medical imaging startups. Learn more at http://www.optellum.com/.

BluMaiden Biosciences is a biotechnology company that adopts a human-first approach. We enable better drug discovery by probing the vastness of chemical space hidden within the human microbiome. Leveraging immense AI-powered computational genetics and chemistry engines, we illuminate new frontiers for new medicines. The Company is currently involved in several clinical trials and collaborations with clinical institutions, biotechnology companies, and Pharma to address challenges and provide enhanced support in clinical research and drug discovery. Run by an accomplished founding team and backed by a panel of experienced global investors and scientific advisors, BluMaiden is building a sustainable business with an enduring competitive advantage.

Edtopia was founded in 2018 as an Oxford University edtech spinout with a mission to make outstanding education available to all. The company's adaptive learning IP - developed by Professor Francis Brown - supported over a million users to benefit from personalised learning and was the subject of a private acquisition in 2021.

Perspectums imaging solutions are safe, fast, and can offer more comprehensive diagnostics. We help doctors understand complex data and help deliver precision care to more patients. We believe the voice of the patient matters and that each case is unique. Our goal is to enable health care providers to tailor precision medicine to the needs of the individual.